Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stevens-Johnson Syndrome”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Testing effectiveness (Phase 2)UnknownNCT00845117
What this trial is testing

Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency

Who this might be right for
Limbal Stem Cell Deficiency
Ethisch Comité UZ Antwerpen 21
Testing effectiveness (Phase 2)UnknownNCT05520086
What this trial is testing

Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.

Who this might be right for
Chronic ConjunctivitisStevens-Johnson SyndromeLyell Syndrome+1 more
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 20
Not applicableStudy completedNCT05320653
What this trial is testing

Nutritional and Metabolic Management of Toxidermia Patients Requiring Intensive Care (TEN Metabolism)

Who this might be right for
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
Centre Hospitalier Universitaire Vaudois 35
Not applicableLooking for participantsNCT03659227
What this trial is testing

Drug Reactions Sampling (COLLECTIONTOXIDERMIES)

Who this might be right for
Stevens-Johnson SyndromeLyell SyndromeDrug Reactions+5 more
Assistance Publique - Hôpitaux de Paris 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Large-scale testing (Phase 3)Study completedNCT01696500
What this trial is testing

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Nihon Pharmaceutical Co., Ltd 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT07369622
What this trial is testing

HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness

Who this might be right for
Gout Initiating Urate-loweringUrate-lowering TherapyGout ArthritisGout and Hyperuricemia
Haiphong University of Medicine and Pharmacy 228
Not applicableUnknownNCT05145959
What this trial is testing

Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal NecrolysesOcular Surface Disease+3 more
Massachusetts Eye and Ear Infirmary 30
Not applicableEnded earlyNCT04313725
What this trial is testing

Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease

Who this might be right for
Stevens-Johnson SyndromeGraft Versus Host Disease in EyeSjogren's Syndrome+1 more
Tangible Science 28
Not applicableAvailableNCT02149732
What this trial is testing

Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation

Who this might be right for
Limbal Stem Cell DeficiencyStevens-johnson SyndromeOcular Cicatricial Pemphigoid+1 more
Seoul National University Hospital
Not applicableUnknownNCT03046914
What this trial is testing

HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction

Who this might be right for
Stevens-Johnson SyndromeKidney Failure, Chronic
Seoul National University Hospital 600
Post-approval studies (Phase 4)Study completedNCT01488396
What this trial is testing

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

Who this might be right for
Stevens-Johnson Syndrome
Mahidol University 31
Not applicableStudy completedNCT06474078
What this trial is testing

Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Chang Gung Memorial Hospital 20
Not applicableStudy completedNCT06522048
What this trial is testing

SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

Who this might be right for
Immune Checkpoint Inhibitor-Induced DermatitisStevens-Johnson Syndrome, Drug-InducedToxic Epidermal Necrolysis Due to Drug
Chao Ji 300
Not applicableStudy completedNCT06263140
What this trial is testing

Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control Study

Who this might be right for
Stevens-Johnson SyndromeDrug Reaction With Eosinophilia and Systemic SymptomMaculopapular Exanthem+2 more
Chulalongkorn University 120
Large-scale testing (Phase 3)Study completedNCT02987257
What this trial is testing

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolyses
Vanderbilt University Medical Center 2
Testing effectiveness (Phase 2)WithdrawnNCT01256489
What this trial is testing

Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)

Who this might be right for
Stevens-Johnson SyndromeCorneal Blindness
Massachusetts Eye and Ear Infirmary
Large-scale testing (Phase 3)Looking for participantsNCT04651439
What this trial is testing

Severe Bullous Drug Eruption and Filgrastim

Who this might be right for
Rare DiseasesToxic Epidermal Necrolyses
Hospices Civils de Lyon 42
Not applicableUnknownNCT04252651
What this trial is testing

Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients

Who this might be right for
Inflammatory ResponseMulti Organ FailureNosocomial Infection+1 more
Joseph M. Still Research Foundation, Inc. 65
Not applicableStudy completedNCT02945176
What this trial is testing

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Who this might be right for
Graft vs Host DiseaseCongenital AniridiaChemical Burns+2 more
Implandata Ophthalmic Products GmbH 13
Load More Results